Disorders of neurotransmission

Physician's Guide to the Treatment and Follow-Up of Metabolic Diseases

Volumn , Issue , 2006, Pages 35-42

  Hoffmann, Georg F ^a   Surtees, Robert ^b  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 62149146693     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/3-540-28962-3_4     Document Type: Chapter

References (15)

1. Baxter P (2001) Pyridoxine dependent and pyridoxine responsive seizures. In: Baxter P (ed) Vitamin responsive conditions in paediatric neurology.MacKeith, London, pp 166-175
2. Becker C-M (1995) Glycine receptors: molecular heterogeneity and implications for disease. Neuroscientist 1:130-141
3. Biaggioni I, Robertson D (1987) Endogenous restoration of noradrenaline by precursor therapy in dopamine-beta-hydroxylase deficiency. Lancet 2:1170-1172
4. Biaggioni I, Goldstein DS, Atkinson T, Robertson D (1990) Dopamine β-hydroxylase deficiency in humans. Neurology 40:370-373
5. Birnbacher R, Scheibenreiter S, Blau N, Bieglmayer C, Frisch H, Waldhauser F (1998) Hyperprolactinemia, a tool in treatment control of tetrahydrobiopterin deficiency: endocrine studies in an affected girl. Ped Res 43:472-477
6. Brunner HG, Nelen MR, Zandvoort P van, Abeling NGGM, Gennip AH van,Wolters EC, Kuiper MA, Ropers HH, Oost BA van (1993) X-linked borderline mental retardation with prominent behavioral disturbance: phenotype, genetic localisation, and evidence for disturbed monoamine metabolism. Am J Hum Genet 52:1-8
7. Cheung NW, Earl J (2002) Monoamine oxidase deficiency. A cause of symptomatic hyperserotoninemia in the absence of carcinoid. Arch Inter Med 162:1647-1648
8. Clayton PT, Surtees RAH, DeVile C, Hyland K, Heales SJR (2003) Neonatal epileptic encephalopathy. Lancet 361:1614
9. Hoffmann GF, Surtees RAH, Wevers RA (1998) Cerebrospinal fluid investigations for neurometabolic disorders. Neuropediatrics 29:59-71
10. Hoffmann GF, Assmann B, Bräutigam C, Dionisis-Vici C, Häussler M, Klerk J de, Naumann M, Steenbergen-Spanjers G, Strassburg HM,Wevers RA (2003) Tyrosine hydroxylase deficiency causes progressive encephalopathy and dopa-nonresponsive dystonia. Ann Neurol (Suppl. 6) 54:56-65
11. Hyland K, Buist NRM, Powell BR,Hoffmann GF, RatingD,McGrath J, Acworth IN (1995) Folinic acid responsive seizures: a new syndrome? J Inher Metab Dis 18:177-181
12. Surtees R, Clayton P (1998) Infantile parkinsonism-dystonia: tyrosine hydroxylase deficiency. Movement Disord 13:350
13. Surtees R, Hyland K (1990) l-3,4-Dihydroxyphenylalanine (levodopa) lowers central nervous system S-Adenosylmethionine concentrations in humans. J Neurol Neurosurg Psychiatr 53:569-572
14. Swoboda KJ, Saul JP, McKenna CE, Speller NB, Hyland K (2003) Aromatic l-Amino acid decarboxylase deficiency. Overview of clinical features and outcomes. Ann Neurol (Suppl. 6) 54:49-55
15. Tijssen MA, Schoemaker HC, Edelbroek PJ, Roos RA, Cohen AF, Dijk JG van (1997) The effects of clonazepam and vigabatrin in hyperekplexia. J Neurol Sci 149:63-67